Words of Wisdom:

"This is a sign from god, that brown haired man you saw today is my son - worship him" - Kiemai

Report on Global Cancer Biosimilars Market Opportunity Outlook 2015

  • Date Submitted: 09/24/2015 05:02 AM
  • Flesch-Kincaid Score: 21 
  • Words: 878
  • Essay Grade: no grades
  • Report this Essay
This report attempts to blend the factual status of the sector and present a dossier which would be first of its kind and would enable clients with reliable insights and better understanding of the coal and its consuming sectors in the country. (https://www.bharatbook.com/healthcare-market-research-reports-673489/global-cancer-biosimilars.html). Cancer incidences are escalating tremendously across the globe due to which burgeoning pressure has been created on pharmaceutical companies to come forth with viable products. Moreover, presently available drugs for cancer treatment are known for their superior pharmacological benefits along with their significantly higher prices. Most of the cancer patients are unable to afford them due to financial constraints. Simultaneously, they have also created lot of financial burden on healthcare system due to which various regulators are unable to offer better facilities to cancer patients. Administration of biosimilars for various malignancies has been proposed to alleviate patient’s medical condition and development of sustainable healthcare system. They are developed after expiry of patent protection and associated rights due to which they have lesser cost as compared to originator molecule. However, cancer biosimilar has not been introduced in limited markets and other available products are used in supportive cancer care.
Market introduction of cancer biosimilar is required because they have both high pharmacological and commercialization potential. Chemotherapeutic drugs have dominated the cancer segment for several decade but various new modalities have been introduced in past few years. They are biologic in origin and consist of plethora of therapeutics for numerous cancer indications. They have higher therapeutic efficacy and lesser side effects as compared to chemotherapeutics. Their cost may be high but therapeutic benefits offered by them offers lucrative choice to cancer patients. Some of the cancer biologics are...

Comments

Express your owns thoughts and ideas on this essay by writing a grade and/or critique.

  1. No comments